Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00651976
Title Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors Vanderbilt-Ingram Cancer Center
Indications

breast cancer

Therapies

Letrozole

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Atlanta Georgia United States Details
Surgical Associates, Inc. Tulsa Oklahoma 74136 United States Details
Allegheny Cancer Center Pittsburgh Pennsylvania 15212 United States Details
Vanderbilt-Ingram Cancer Center, One Hundred Oaks Nashville Tennessee 37204 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field